IP Library Granted Patent US 11,524,946
Granted Patent B2
US 11,524,946 · App. 16/712,098 · Granted Dec 13, 2022

Polymerase inhibitors and related compositions and methods

Inventors: Wenhui Zhou (Madison, WI); Kimberly K. Knoche (Madison, WI); Douglas R. Storts (Madison, WI); Min Zhou (Madison, WI); Poncho Meisenheimer (Madison, WI)
Assignee: Promega Corporation
C07D307/42C07C317/28C07D307/80C07D311/58C12N9/1252C12P19/34C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,524,946
App. No.
16/712,098
Granted
Dec 13, 2022
Kind
B2
Abstract

The present disclosure includes compositions and methods for improved DNA amplification reactions. In particular, the present disclosure provides compositions and methods for hot-start PCR applications using DNA polymerase inhibitors that minimize non-specific DNA amplification by inactivating DNA polymerase at lower temperatures.

Claims (18)

1. A compound of formula (I):

or a salt thereof,

wherein:

A is selected from aryl, heteroaryl, and heterocyclyl, each of which may be optionally substituted with 1, 2, or 3 substituents;

R 1 is C 6 -C 20 alkyl;

R 2 is selected from hydrogen and —COOH; and

n is 1 or 2.

2. The compound of claim 1 , or a salt thereof, wherein A is phenyl that is unsubstituted or substituted with 1, 2, or 3 substituents independently selected from C 1 -C 4 alkyl, C 1 -C 4 alkoxy, and halo.

3. The compound of claim 1 , or a salt thereof, wherein A is a 5- or 6-membered monocyclic heteroaryl that is unsubstituted or substituted with 1, 2, or 3 substituents independently selected from C 1 -C 4 alkyl, C 1 -C 4 alkoxy, and halo.

4. The compound of claim 1 , or a salt thereof, wherein A is a bicyclic heterocyclyl group that is unsubstituted.

5. The compound of claim 1 , or a salt thereof, wherein R 1 is C 8 -C 14 alkyl.

6. The compound of claim 1 , wherein the compound is selected from:

or a salt thereof.

7. A composition comprising a compound claim 1 or a salt thereof, and a thermostable DNA polymerase.

8. The composition of claim 7 , wherein the thermostable DNA polymerase is selected from the group consisting of: Taq, Tca, Tfu, Tbr, Tth, Tih, Tfi, Tli, Tfl, Pfu, Pwo, KOD, Tma, Tne, Bst, Pho, Sac, Sso, ES4, or a mutant, variant or derivative thereof.

9. The composition of claim 7 , wherein the compound is bound to the DNA polymerase and inhibits the activity of the DNA polymerase.

10. The composition of claim 7 , further comprising one or more nucleic acid amplification reagents selected from the group consisting of: deoxynucleotide triphosphates, buffer, a magnesium salt, an oligonucleotide primer, and a nucleic acid template.

11. A composition comprising a compound of claim 1 or a salt thereof, and one or more nucleic acid amplification reagents selected from the group consisting of: a polymerase, deoxynucleotide triphosphates, buffer, a magnesium salt, an oligonucleotide primer, and a nucleic acid template.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2020
From: ZHOU, WENHUI; KNOCHE, KIMBERLY K.; STORTS, DOUGLAS R.; ZHOU, MIN; MEISENHEIMER, PONCHO
To: PROMEGA CORPORATION
Reel/Frame 052226/0610 →
Continuity (2)
Provisional Application 62778590 · Dec 12, 2018
Related Publication 20200199088A1 · Jun 25, 2020
Cited By (1)
US 12,291,511